Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.3 Forecast parameters
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Public sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Compounding pharmacies industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Therapeutic area trends
2.1.3 Product trends
2.1.4 Application trends
2.1.5 Compounding type trends
2.1.6 Sterility trends
2.1.7 Distribution channel trends
2.1.8 Regional trends
Chapter 3 Compounding Pharmacies Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry ecosystem analysis
3.3.1 Distribution channel analysis
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Rising geriatric population and improved life expectancy across the globe
3.4.1.2 Rising adoption of customized medicine in the developed regions
3.4.1.3 Shortage of drugs across the globe
3.4.1.4 Benefits of compounded medication
3.4.1.5 Growing drug failure rate
3.4.2 Industry pitfalls & challenges
3.4.2.1 Lack of skilled lab technicians and pharmacists in developed economies
3.4.2.2 High cost of equipment and maintenance of sterile environment
3.4.2.3 Volatile regulatory scenario
3.4.2.4 Consumer perception towards compounded drugs
3.5 Growth potential analysis
3.5.1 By therapeutic area
3.5.2 By product
3.5.3 By application
3.5.4 By compounding type
3.5.5 By sterility
3.5.6 By distribution type
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Australia
3.7 Reimbursement landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Australia
3.8 COVID- 19 impact analysis
3.9 Porter's analysis
3.10 Competitive landscape, 2021
3.10.1 Company matrix analysis, 2021
3.11 PESTEL analysis
Chapter 4 Compounding Pharmacies Market, By Therapeutic Area
4.1 Key segment trends
4.2 Hormone replacement
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Pain management
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Dermatology applications
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Specialty drugs
4.5.1 Market size, by region, 2017-2030 (USD Million)
4.6 Nutritional supplements
4.6.1 Market size, by region, 2017-2030 (USD Million)
4.7 Others
4.7.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Compounding Pharmacies Market, By Product
5.1 Key segment trends
5.2 Oral
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2 Solid preparations
5.2.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.2 Tablets
5.2.2.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.3 Capsules
5.2.2.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.4 Granules
5.2.2.4.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.5 Powder
5.2.2.5.1 Market size, by region, 2017-2030 (USD Million)
5.2.2.6 Others
5.2.2.6.1 Market size, by region, 2017-2030 (USD Million)
5.2.3 Liquid preparations
5.2.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.2 Solution
5.2.3.2.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.3 Suspension
5.2.3.3.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.4 Emulsion
5.2.3.4.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.5 Syrup
5.2.3.5.1 Market size, by region, 2017-2030 (USD Million)
5.2.3.6 Others
5.2.3.6.1 Market size, by region, 2017-2030 (USD Million)
5.3 Topical
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.3.2 Ointments
5.3.2.1 Market size, by region, 2017-2030 (USD Million)
5.3.3 Creams
5.3.3.1 Market size, by region, 2017-2030 (USD Million)
5.3.4 Gels
5.3.4.1 Market size, by region, 2017-2030 (USD Million)
5.3.5 Pastes
5.3.5.1 Market size, by region, 2017-2030 (USD Million)
5.3.6 Others
5.3.6.1 Market size, by region, 2017-2030 (USD Million)
5.4 Rectal
5.4.1 Market size, by region, 2017-2030 (USD Million)
5.4.2 Suppositories
5.4.2.1 Market size, by region, 2017-2030 (USD Million)
5.4.3 Enema
5.4.3.1 Market size, by region, 2017-2030 (USD Million)
5.4.4 Others
5.4.4.1 Market size, by region, 2017-2030 (USD Million)
5.5 Parenteral
5.5.1 Market size, by region, 2017-2030 (USD Million)
5.5.2 LVP
5.5.2.1 Market size, by region, 2017-2030 (USD Million)
5.5.3 SVP
5.5.3.1 Market size, by region, 2017-2030 (USD Million)
5.6 Nasal
5.6.1 Market size, by region, 2017-2030 (USD Million)
5.7 Ophthalmic
5.7.1 Market size, by region, 2017-2030 (USD Million)
5.8 Otic
5.8.1 Market size, by region, 2017-2030 (USD Million)
Chapter 6 Compounding Pharmacies Market, By Application
6.1 Key segment trends
6.2 Pediatric
6.2.1 Market size, by region, 2017-2030 (USD Million)
6.3 Adult
6.3.1 Market size, by region, 2017-2030 (USD Million)
6.4 Geriatric
6.4.1 Market size, by region, 2017-2030 (USD Million)
6.5 Veterinary
6.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 7 Compounding Pharmacies Market, By Compounding Type
7.1 Key segment trends
7.2 Pharmaceutical Ingredient Alteration (PIA)
7.2.1 Market size, by region, 2017-2030 (USD Million)
7.3 Currently Unavailable Pharmaceutical Manufacturing (CUPM)
7.3.1 Market size, by region, 2017-2030 (USD Million)
7.4 Pharmaceutical Dosage Alteration (PDA)
7.4.1 Market size, by region, 2017-2030 (USD Million)
7.5 Others
7.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 8 Compounding Pharmacies Market, By Sterility
8.1 Key segment trends
8.2 Sterile
8.2.1 Market size, by region, 2017-2030 (USD Million)
8.3 Non-sterile
8.3.1 Market size, by region, 2017-2030 (USD Million)
Chapter 9 Compounding Pharmacies Market, By Distribution Channel
9.1 Key segment trends
9.2 Hospital pharmacy
9.2.1 Market size, by region, 2017-2030 (USD Million)
9.3 Compounding pharmacy
9.3.1 Market size, by region, 2017-2030 (USD Million)
9.4 Others
9.4.1 Market size, by region, 2017-2030 (USD Million)
Chapter 10 Compounding Pharmacies Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 Market size, by country, 2017 - 2030 (USD Million)
10.2.2 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.2.3 Market size, by product, 2017 - 2030 (USD Million)
10.2.3.1 Market size, by oral, 2017 – 2030
10.2.3.1.1 Market size, by solid preparation, 2017 – 2030
10.2.3.1.2 Market size, by liquid preparation, 2017 – 2030
10.2.3.2 Market size, by topical, 2017 – 2030
10.2.3.3 Market size, by rectal, 2017 – 2030
10.2.3.4 Market size, by parenteral, 2017 – 2030
10.2.4 Market size, by application, 2017 - 2030 (USD Million)
10.2.5 Market size, by compounding type, 2017 - 2030 (USD Million)
10.2.6 Market size, by sterility, 2017 - 2030 (USD Million)
10.2.7 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.2.8 U.S.
10.2.8.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.2.8.2 Market size, by product, 2017 - 2030 (USD Million)
10.2.8.2.1 Market size, by oral, 2017 – 2030
10.2.8.2.1.1 Market size, by solid preparation, 2017 – 2030
10.2.8.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.2.8.2.2 Market size, by topical, 2017 – 2030
10.2.8.2.3 Market size, by rectal, 2017 – 2030
10.2.8.2.4 Market size, by parenteral, 2017 – 2030
10.2.8.3 Market size, by application, 2017 - 2030 (USD Million)
10.2.8.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.2.8.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.2.8.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.2.9 Canada
10.2.9.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.2.9.2 Market size, by product, 2017 - 2030 (USD Million)
10.2.9.2.1 Market size, by oral, 2017 – 2030
10.2.9.2.1.1 Market size, by solid preparation, 2017 – 2030
10.2.9.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.2.9.2.2 Market size, by topical, 2017 – 2030
10.2.9.2.3 Market size, by rectal, 2017 – 2030
10.2.9.2.4 Market size, by parenteral, 2017 – 2030
10.2.9.3 Market size, by application, 2017 - 2030 (USD Million)
10.2.9.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.2.9.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.2.9.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3 Europe
10.3.1 Market size, by country, 2017 - 2030 (USD Million)
10.3.2 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.3 Market size, by product, 2017 - 2030 (USD Million)
10.3.3.1 Market size, by oral, 2017 – 2030
10.3.3.1.1 Market size, by solid preparation, 2017 – 2030
10.3.3.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.3.2 Market size, by topical, 2017 – 2030
10.3.3.3 Market size, by rectal, 2017 – 2030
10.3.3.4 Market size, by parenteral, 2017 – 2030
10.3.4 Market size, by application, 2017 - 2030 (USD Million)
10.3.5 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.6 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.7 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.8 Germany
10.3.8.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.8.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.8.2.1 Market size, by oral, 2017 – 2030
10.3.8.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.8.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.8.2.2 Market size, by topical, 2017 – 2030
10.3.8.2.3 Market size, by rectal, 2017 – 2030
10.3.8.2.4 Market size, by parenteral, 2017 – 2030
10.3.8.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.8.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.8.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.8.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.9 UK
10.3.9.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.9.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.9.2.1 Market size, by oral, 2017 – 2030
10.3.9.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.9.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.9.2.2 Market size, by topical, 2017 – 2030
10.3.9.2.3 Market size, by rectal, 2017 – 2030
10.3.9.2.4 Market size, by parenteral, 2017 – 2030
10.3.9.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.9.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.9.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.9.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.10 France
10.3.10.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.10.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.10.2.1 Market size, by oral, 2017 – 2030
10.3.10.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.10.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.10.2.2 Market size, by topical, 2017 – 2030
10.3.10.2.3 Market size, by rectal, 2017 – 2030
10.3.10.2.4 Market size, by parenteral, 2017 – 2030
10.3.10.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.10.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.10.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.10.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.11 Italy
10.3.11.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.11.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.11.2.1 Market size, by oral, 2017 – 2030
10.3.11.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.11.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.11.2.2 Market size, by topical, 2017 – 2030
10.3.11.2.3 Market size, by rectal, 2017 – 2030
10.3.11.2.4 Market size, by parenteral, 2017 – 2030
10.3.11.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.11.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.11.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.11.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.12 Spain
10.3.12.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.12.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.12.2.1 Market size, by oral, 2017 – 2030
10.3.12.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.12.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.12.2.2 Market size, by topical, 2017 – 2030
10.3.12.2.3 Market size, by rectal, 2017 – 2030
10.3.12.2.4 Market size, by parenteral, 2017 – 2030
10.3.12.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.12.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.12.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.12.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.13 Poland
10.3.13.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.13.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.13.2.1 Market size, by oral, 2017 – 2030
10.3.13.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.13.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.13.2.2 Market size, by topical, 2017 – 2030
10.3.13.2.3 Market size, by rectal, 2017 – 2030
10.3.13.2.4 Market size, by parenteral, 2017 – 2030
10.3.13.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.13.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.13.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.13.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.14 Ukraine
10.3.14.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.14.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.14.2.1 Market size, by oral, 2017 – 2030
10.3.14.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.14.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.14.2.2 Market size, by topical, 2017 – 2030
10.3.14.2.3 Market size, by rectal, 2017 – 2030
10.3.14.2.4 Market size, by parenteral, 2017 – 2030
10.3.14.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.14.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.14.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.14.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.15 Greece
10.3.15.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.15.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.15.2.1 Market size, by oral, 2017 – 2030
10.3.15.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.15.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.15.2.2 Market size, by topical, 2017 – 2030
10.3.15.2.3 Market size, by rectal, 2017 – 2030
10.3.15.2.4 Market size, by parenteral, 2017 – 2030
10.3.15.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.15.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.15.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.15.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.16 Sweden
10.3.16.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.16.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.16.2.1 Market size, by oral, 2017 – 2030
10.3.16.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.16.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.16.2.2 Market size, by topical, 2017 – 2030
10.3.16.2.3 Market size, by rectal, 2017 – 2030
10.3.16.2.4 Market size, by parenteral, 2017 – 2030
10.3.16.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.16.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.16.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.16.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.17 Norway
10.3.17.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.17.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.17.2.1 Market size, by oral, 2017 – 2030
10.3.17.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.17.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.17.2.2 Market size, by topical, 2017 – 2030
10.3.17.2.3 Market size, by rectal, 2017 – 2030
10.3.17.2.4 Market size, by parenteral, 2017 – 2030
10.3.17.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.17.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.17.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.17.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.18 Belgium
10.3.18.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.18.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.18.2.1 Market size, by oral, 2017 – 2030
10.3.18.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.18.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.18.2.2 Market size, by topical, 2017 – 2030
10.3.18.2.3 Market size, by rectal, 2017 – 2030
10.3.18.2.4 Market size, by parenteral, 2017 – 2030
10.3.18.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.18.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.18.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.18.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.19 Czech Republic
10.3.19.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.19.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.19.2.1 Market size, by oral, 2017 – 2030
10.3.19.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.19.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.19.2.2 Market size, by topical, 2017 – 2030
10.3.19.2.3 Market size, by rectal, 2017 – 2030
10.3.19.2.4 Market size, by parenteral, 2017 – 2030
10.3.19.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.19.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.19.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.19.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.20 Finland
10.3.20.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.20.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.20.2.1 Market size, by oral, 2017 – 2030
10.3.20.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.20.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.20.2.2 Market size, by topical, 2017 – 2030
10.3.20.2.3 Market size, by rectal, 2017 – 2030
10.3.20.2.4 Market size, by parenteral, 2017 – 2030
10.3.20.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.20.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.20.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.20.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.3.21 Russia
10.3.21.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.3.21.2 Market size, by product, 2017 - 2030 (USD Million)
10.3.21.2.1 Market size, by oral, 2017 – 2030
10.3.21.2.1.1 Market size, by solid preparation, 2017 – 2030
10.3.21.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.3.21.2.2 Market size, by topical, 2017 – 2030
10.3.21.2.3 Market size, by rectal, 2017 – 2030
10.3.21.2.4 Market size, by parenteral, 2017 – 2030
10.3.21.3 Market size, by application, 2017 - 2030 (USD Million)
10.3.21.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.3.21.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.3.21.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Market size, by country, 2017 - 2030 (USD Million)
10.4.2 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.3 Market size, by product, 2017 - 2030 (USD Million)
10.4.3.1 Market size, by oral, 2017 – 2030
10.4.3.1.1 Market size, by solid preparation, 2017 – 2030
10.4.3.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.3.2 Market size, by topical, 2017 – 2030
10.4.3.3 Market size, by rectal, 2017 – 2030
10.4.3.4 Market size, by parenteral, 2017 – 2030
10.4.4 Market size, by application, 2017 - 2030 (USD Million)
10.4.5 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.6 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.7 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4.8 Japan
10.4.8.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.8.2 Market size, by product, 2017 - 2030 (USD Million)
10.4.8.2.1 Market size, by oral, 2017 – 2030
10.4.8.2.1.1 Market size, by solid preparation, 2017 – 2030
10.4.8.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.8.2.2 Market size, by topical, 2017 – 2030
10.4.8.2.3 Market size, by rectal, 2017 – 2030
10.4.8.2.4 Market size, by parenteral, 2017 – 2030
10.4.8.3 Market size, by application, 2017 - 2030 (USD Million)
10.4.8.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.8.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.8.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4.9 China
10.4.9.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.9.2 Market size, by product, 2017 - 2030 (USD Million)
10.4.9.2.1 Market size, by oral, 2017 – 2030
10.4.9.2.1.1 Market size, by solid preparation, 2017 – 2030
10.4.9.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.9.2.2 Market size, by topical, 2017 – 2030
10.4.9.2.3 Market size, by rectal, 2017 – 2030
10.4.9.2.4 Market size, by parenteral, 2017 – 2030
10.4.9.3 Market size, by application, 2017 - 2030 (USD Million)
10.4.9.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.9.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.9.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4.10 India
10.4.10.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.10.2 Market size, by product, 2017 - 2030 (USD Million)
10.4.10.2.1 Market size, by oral, 2017 – 2030
10.4.10.2.1.1 Market size, by solid preparation, 2017 – 2030
10.4.10.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.10.2.2 Market size, by topical, 2017 – 2030
10.4.10.2.3 Market size, by rectal, 2017 – 2030
10.4.10.2.4 Market size, by parenteral, 2017 – 2030
10.4.10.3 Market size, by application, 2017 - 2030 (USD Million)
10.4.10.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.10.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.10.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4.11 Singapore
10.4.11.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.11.2 Market size, by product, 2017 - 2030 (USD Million)
10.4.11.2.1 Market size, by oral, 2017 – 2030
10.4.11.2.1.1 Market size, by solid preparation, 2017 – 2030
10.4.11.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.11.2.2 Market size, by topical, 2017 – 2030
10.4.11.2.3 Market size, by rectal, 2017 – 2030
10.4.11.2.4 Market size, by parenteral, 2017 – 2030
10.4.11.3 Market size, by application, 2017 - 2030 (USD Million)
10.4.11.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.11.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.11.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.4.12 Australia
10.4.12.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.4.12.2 Market size, by product, 2017 - 2030 (USD Million)
10.4.12.2.1 Market size, by oral, 2017 – 2030
10.4.12.2.1.1 Market size, by solid preparation, 2017 – 2030
10.4.12.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.4.12.2.2 Market size, by topical, 2017 – 2030
10.4.12.2.3 Market size, by rectal, 2017 – 2030
10.4.12.2.4 Market size, by parenteral, 2017 – 2030
10.4.12.3 Market size, by application, 2017 - 2030 (USD Million)
10.4.12.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.4.12.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.4.12.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.5 Latin America
10.5.1 Market size, by country, 2017 - 2030 (USD Million)
10.5.2 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.5.3 Market size, by product, 2017 - 2030 (USD Million)
10.5.3.1 Market size, by oral, 2017 – 2030
10.5.3.1.1 Market size, by solid preparation, 2017 – 2030
10.5.3.1.2 Market size, by liquid preparation, 2017 – 2030
10.5.3.2 Market size, by topical, 2017 – 2030
10.5.3.3 Market size, by rectal, 2017 – 2030
10.5.3.4 Market size, by parenteral, 2017 – 2030
10.5.4 Market size, by application, 2017 - 2030 (USD Million)
10.5.5 Market size, by compounding type, 2017 - 2030 (USD Million)
10.5.6 Market size, by sterility, 2017 - 2030 (USD Million)
10.5.7 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.5.8 Brazil
10.5.8.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.5.8.2 Market size, by product, 2017 - 2030 (USD Million)
10.5.8.2.1 Market size, by oral, 2017 – 2030
10.5.8.2.1.1 Market size, by solid preparation, 2017 – 2030
10.5.8.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.5.8.2.2 Market size, by topical, 2017 – 2030
10.5.8.2.3 Market size, by rectal, 2017 – 2030
10.5.8.2.4 Market size, by parenteral, 2017 – 2030
10.5.8.3 Market size, by application, 2017 - 2030 (USD Million)
10.5.8.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.5.8.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.5.8.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.5.9 Mexico
10.5.9.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.5.9.2 Market size, by product, 2017 - 2030 (USD Million)
10.5.9.2.1 Market size, by oral, 2017 – 2030
10.5.9.2.1.1 Market size, by solid preparation, 2017 – 2030
10.5.9.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.5.9.2.2 Market size, by topical, 2017 – 2030
10.5.9.2.3 Market size, by rectal, 2017 – 2030
10.5.9.2.4 Market size, by parenteral, 2017 – 2030
10.5.9.3 Market size, by application, 2017 - 2030 (USD Million)
10.5.9.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.5.9.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.5.9.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.5.10 Argentina
10.5.10.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.5.10.2 Market size, by product, 2017 - 2030 (USD Million)
10.5.10.2.1 Market size, by oral, 2017 – 2030
10.5.10.2.1.1 Market size, by solid preparation, 2017 – 2030
10.5.10.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.5.10.2.2 Market size, by topical, 2017 – 2030
10.5.10.2.3 Market size, by rectal, 2017 – 2030
10.5.10.2.4 Market size, by parenteral, 2017 – 2030
10.5.10.3 Market size, by application, 2017 - 2030 (USD Million)
10.5.10.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.5.10.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.5.10.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6 Middle East & Africa
10.6.1 Market size, by country, 2017 - 2030 (USD Million)
10.6.2 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.3 Market size, by product, 2017 - 2030 (USD Million)
10.6.3.1 Market size, by oral, 2017 – 2030
10.6.3.1.1 Market size, by solid preparation, 2017 – 2030
10.6.3.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.3.2 Market size, by topical, 2017 – 2030
10.6.3.3 Market size, by rectal, 2017 – 2030
10.6.3.4 Market size, by parenteral, 2017 – 2030
10.6.4 Market size, by application, 2017 - 2030 (USD Million)
10.6.5 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.6 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.7 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6.8 Saudi Arabia
10.6.8.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.8.2 Market size, by product, 2017 - 2030 (USD Million)
10.6.8.2.1 Market size, by oral, 2017 – 2030
10.6.8.2.1.1 Market size, by solid preparation, 2017 – 2030
10.6.8.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.8.2.2 Market size, by topical, 2017 – 2030
10.6.8.2.3 Market size, by rectal, 2017 – 2030
10.6.8.2.4 Market size, by parenteral, 2017 – 2030
10.6.8.3 Market size, by application, 2017 - 2030 (USD Million)
10.6.8.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.8.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.8.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6.9 UAE
10.6.9.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.9.2 Market size, by product, 2017 - 2030 (USD Million)
10.6.9.2.1 Market size, by oral, 2017 – 2030
10.6.9.2.1.1 Market size, by solid preparation, 2017 – 2030
10.6.9.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.9.2.2 Market size, by topical, 2017 – 2030
10.6.9.2.3 Market size, by rectal, 2017 – 2030
10.6.9.2.4 Market size, by parenteral, 2017 – 2030
10.6.9.3 Market size, by application, 2017 - 2030 (USD Million)
10.6.9.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.9.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.9.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6.10 South Africa
10.6.10.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.10.2 Market size, by product, 2017 - 2030 (USD Million)
10.6.10.2.1 Market size, by oral, 2017 – 2030
10.6.10.2.1.1 Market size, by solid preparation, 2017 – 2030
10.6.10.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.10.2.2 Market size, by topical, 2017 – 2030
10.6.10.2.3 Market size, by rectal, 2017 – 2030
10.6.10.2.4 Market size, by parenteral, 2017 – 2030
10.6.10.3 Market size, by application, 2017 - 2030 (USD Million)
10.6.10.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.10.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.10.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6.11 Qatar
10.6.11.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.11.2 Market size, by product, 2017 - 2030 (USD Million)
10.6.11.2.1 Market size, by oral, 2017 – 2030
10.6.11.2.1.1 Market size, by solid preparation, 2017 – 2030
10.6.11.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.11.2.2 Market size, by topical, 2017 – 2030
10.6.11.2.3 Market size, by rectal, 2017 – 2030
10.6.11.2.4 Market size, by parenteral, 2017 – 2030
10.6.11.3 Market size, by application, 2017 - 2030 (USD Million)
10.6.11.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.11.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.11.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
10.6.12 Kuwait
10.6.12.1 Market size, by therapeutic area, 2017 - 2030 (USD Million)
10.6.12.2 Market size, by product, 2017 - 2030 (USD Million)
10.6.12.2.1 Market size, by oral, 2017 – 2030
10.6.12.2.1.1 Market size, by solid preparation, 2017 – 2030
10.6.12.2.1.2 Market size, by liquid preparation, 2017 – 2030
10.6.12.2.2 Market size, by topical, 2017 – 2030
10.6.12.2.3 Market size, by rectal, 2017 – 2030
10.6.12.2.4 Market size, by parenteral, 2017 – 2030
10.6.12.3 Market size, by application, 2017 - 2030 (USD Million)
10.6.12.4 Market size, by compounding type, 2017 - 2030 (USD Million)
10.6.12.5 Market size, by sterility, 2017 - 2030 (USD Million)
10.6.12.6 Market size, by distribution channel, 2017 - 2030 (USD Million)
Chapter 11 Company Profiles
11.1 Strategy dashboard, 2021
11.2 Athenex Pharma Solutions (Athenex Inc.)
11.2.1 Business overview
11.2.2 Financial data
11.2.3 Product landscape
11.2.4 Strategic outlook
11.2.5 SWOT analysis
11.3 B. Braun SE
11.3.1 Business overview
11.3.2 Financial data
11.3.3 Product landscape
11.3.4 Strategic outlook
11.3.5 SWOT analysis
11.4 Clinigen Limited
11.4.1 Business overview
11.4.2 Financial data
11.4.3 Product landscape
11.4.4 Strategic outlook
11.4.5 SWOT analysis
11.5 Dougherty's Pharmacy, Inc.
11.5.1 Business overview
11.5.2 Financial data
11.5.3 Product landscape
11.5.4 Strategic outlook
11.5.5 SWOT analysis
11.6 Fagron
11.6.1 Business overview
11.6.2 Financial data
11.6.3 Product landscape
11.6.4 Strategic outlook
11.6.5 SWOT analysis
11.7 Fresenius Kabi
11.7.1 Business overview
11.7.2 Financial data
11.7.3 Product landscape
11.7.4 Strategic outlook
11.7.5 SWOT analysis
11.8 Institutional Pharmacy Solutions
11.8.1 Business overview
11.8.2 Financial data
11.8.3 Product landscape
11.8.4 Strategic outlook
11.8.5 SWOT analysis
11.9 Lorraine’s Pharmacy
11.9.1 Business overview
11.9.2 Financial data
11.9.3 Product landscape
11.9.4 Strategic outlook
11.9.5 SWOT analysis
11.10 McGuff Company Inc. (McGuff Compounding Pharmacy Services)
11.10.1 Business overview
11.10.2 Financial data
11.10.3 Product landscape
11.10.4 Strategic outlook
11.10.5 SWOT analysis
11.11 Nephron Pharmaceuticals Corporation
11.11.1 Business overview
11.11.2 Financial data
11.11.3 Product landscape
11.11.4 Strategic outlook
11.11.5 SWOT analysis
11.12 Pencol Compounding Pharmacy
11.12.1 Business overview
11.12.2 Financial data
11.12.3 Product landscape
11.12.4 Strategic outlook
11.12.5 SWOT analysis
11.13 Rx3 Compounding Pharmacy
11.13.1 Business overview
11.13.2 Financial data
11.13.3 Product landscape
11.13.4 Strategic outlook
11.13.5 SWOT analysis
11.14 Triangle Compounding Pharmacies
11.14.1 Business overview
11.14.2 Financial data
11.14.3 Product landscape
11.14.4 Strategic outlook
11.14.5 SWOT analysis
11.15 Wedgewood Village Pharmacy, Inc.
11.15.1 Business overview
11.15.2 Financial data
11.15.3 Product landscape
11.15.4 Strategic outlook
11.15.5 SWOT analysis
